News & Research

I spent months talking to psychedelic guides and researchers. Here’s what I learned.

Carine Chen-McLaughlin smoked for more than 40 years.

Nearly five years after a group of cancer patients were given a single dose of a psychedelic drug to ease depression and anxiety, new research finds that many of them are still feeling the positive effects.

The hallucinogenic chemical psilocybin produced in some mushrooms helped people with major depression in a study that also included supportive psychotherapy.

Regulators will soon grapple with how to safely administer powerful psychedelics for treating depression and post-traumatic stress disorder.

03 Oct Psychedelic Mushrooms Are Closer to Medicinal Use (It’s Not Just Your Imagination)

Researchers at Johns Hopkins University have suggested that psilocybin, which is found in hallucinogenic mushrooms, be reclassified from a Schedule I drug, with no known medical benefit, to a Schedule IV drug, which is akin to prescription sleeping pills.Credit…Anthony Devlin/PA Wire, via Associated Press